INLB (Item 9 Labs) Other Current Liabilities: $5.50 Mil (As of Jun. 2023)


INLB Item 9 Labs Corp INLB
12 GF Score
Price $0.00
View Full Analysis

What is Item 9 Labs Other Current Liabilities?

Item 9 Labs INLB -99.00% 12 Other Current Liabilities is $5.50 Mil as of Jun. 2023. GuruFocus rates INLB with a GF Score™ of 12/100.

Item 9 Labs's other current liabilities for the quarter that ended in Jun. 2023 was $5.50 Mil.

Item 9 Labs's quarterly other current liabilities increased from Dec. 2022 ($5.50 Mil) to Mar. 2023 ($5.50 Mil) but then from Mar. 2023 ($5.50 Mil) to Jun. 2023 ($5.50 Mil).

Item 9 Labs's annual other current liabilities stayed the same from Sep. 2020 ($0.00 Mil) to Sep. 2021 ($0.00 Mil) but then increased from Sep. 2021 ($0.00 Mil) to Sep. 2022 ($5.50 Mil).

Item 9 Labs Other Current Liabilities Related Terms

Item 9 Labs Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Item 9 Labs's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Item 9 Labs Other Current Liabilities Chart

Item 9 Labs Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.07 0.00 0.00 5.50

Item 9 Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.50 5.50 5.50 5.50
INLB
12GF Score
Item 9 Labs Corp INLB
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Item 9 Labs Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $5.50 Mil mean?
Item 9 Labs (INLB) has a Other Current Liabilities of $5.50 Mil as of Jun. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Item 9 Labs.
Is Item 9 Labs' Other Current Liabilities too high?
Item 9 Labs' current Other Current Liabilities is $5.50 Mil. Overall, Item 9 Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Item 9 Labs' Other Current Liabilities compare to NEPT and CENBF?
Item 9 Labs' Other Current Liabilities of $5.50 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Item 9 Labs. Item 9 Labs's current Other Current Liabilities is $5.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Item 9 Labs stock overvalued right now?
Item 9 Labs (INLB) has a current Other Current Liabilities of $5.50 Mil. The current Other Current Liabilities is $5.50 Mil. Item 9 Labs' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Item 9 Labs (INLB), the current Other Current Liabilities is $5.50 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Item 9 Labs Business Description

Address 2111 E. Highland Avenue, Suite B375, Phoenix, AZ, USA, 85016
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. It also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
12GF Score

Get the complete analysis for INLB

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price